Zobrazeno 1 - 10
of 241
pro vyhledávání: '"R Amrein"'
Autor:
A.E. Nardi, A.M. Valença, R.C. Freire, M.D. Mochcovitch, R. Amrein, A. Sardinha, M.N. Levitan, I. Nascimento, V.L. de-Melo-Neto, A.L. King, A.C. de O. e Silva, A.B. Veras, G.P. Dias, G.L. Soares-Filho, R.T. da Costa, M.A. Mezzasalma, M.R. de Carvalho, A.C. de Cerqueira, J.E. Hallak, J.A. Crippa, M. Versiani
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 44, Iss 4, Pp 366-373 (2011)
The objective of the present randomized, open-label, naturalistic 8-week study was to compare the efficacy and safety of treatment with clonazepam (N = 63) and paroxetine (N = 57) in patients with panic disorder with or without agoraphobia. Efficacy
Externí odkaz:
https://doaj.org/article/d41503778dab4295b4457c91d37f8d91
Autor:
Jens Rosenbaum, Hans R. Amrein, Hans Amrein, Marco A. Gardini, Philipp Hangartner, Stephan Hirt, Karsten Jeß, Sven Klunker, Luzius Kuchen, Stephan Schulze-Aissen, Rolf Slickers, Thomas G. Zydeck
Publikováno v:
IHA Praxiswissen Hotellerie ISBN: 9783503171736
Ohne Betten keine Gäste: Das Hotel-Bett ist das Basisangebot schlechthin in jedem Hotel und ein oft unterschätzter Erfolgsfaktor. Um von der Beschaffung bis zur Unterhaltung effizient zu kalkulieren, müssen auch gesundheitliche und kulturelle Krit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0286ecd4e8273b0a10e9892fa668b920
https://doi.org/10.37307/b.978-3-503-17173-6
https://doi.org/10.37307/b.978-3-503-17173-6
Publikováno v:
International Clinical Psychopharmacology. 17:161-170
Social phobia (social anxiety disorder) is a highly prevalent and chronic disorder that is associated with significant comorbidity and disability. Despite recent advances in the pharmacotherapy of the disorder, there is a paucity of randomized contro
U. Vianna Filho In his historical evolution, man has been able to dominate nature by means of his technological achievements, his knowledge and his inventiveness, attaining an increasing control over the world and its organization. As a result, his p
Autor:
R. Amrein, A.E. Nardi, S. Hoirisch-Clapauch, Rafael C. Freire, S. Machado, Adriana Cardoso Silva
Publikováno v:
European Neuropsychopharmacology. 25:S567-S568
Publikováno v:
International Clinical Psychopharmacology. 12:183-194
An international, multicenter, placebo-controlled study was undertaken to determine the safety and antidepressant efficacy of moclobemide, a new reversible inhibitor of monoamine oxidase A, and imipramine in the treatment of dysthymia (DSM-III-R). A
Autor:
R. Amrein, J.G. Whitwam
Publikováno v:
Acta Anaesthesiologica Scandinavica. 39:3-14
Flumazenil, an imidazobenzodiazepine, is the first benzodiazepine antagonist available for clinical use. It is a specific competitive antagonist at benzodiazepine receptors, which are associated with receptors for gamma-aminobutyric acid, the most im
Publikováno v:
Clinical Neuropharmacology. 17:S74-S87
Safety aspects [adverse events, blood pressure and heart rate, weight, and laboratory tests (liver parameters, hemoglobin, leukocytes)] of long-term treatment in 1,120 patients are discussed. Adverse events during this long-term treatment were also c